South & Central America Antibiotics & Antimycotics Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The South & Central America antibiotics & antimycotics market size is expected to reach US$ 4,220.27 million by 2031 from US$ 2,968.59 million in 2023. The market is estimated to record a CAGR of 4.5% from 2023 to 2031.

Executive Summary and South & Central America Antibiotics & Antimycotics Market Analysis:

The South & Central America antibiotics and antimycotics market is segmented into Brazil, Argentina, and the Rest of South & Central America. South & Central America occupies a significant position in the antibiotics and antimycotics market and is expected to register a robust growth rate during the forecast period. The major driving factors include the increasing prevalence of bacterial and fungal infections; strategic initiatives adopted by market participants such as product launches, approval, and partnerships; and supportive government initiatives.

South & Central America Antibiotics & Antimycotics Market Strategic Insights

Get more information on this report Request Free Sample PDF

South & Central America Antibiotics & Antimycotics Market Segmentation Analysis

Key segments that contributed to the derivation of the South & Central America antibiotics & antimycotics market analysis are drug class, indication, route of administration, and distribution channel.

• Based on drug class, the South & Central America antibiotics & antimycotics market is segmented into penicillin, cephalosporines, carbapenems, macrolides, aminoglycosides, quinolones, sulfonamides, tetracyclines, azoles, and others. The penicillin held the largest share of the market in 2023.
• Based on indication, the South & Central America antibiotics & antimycotics market is segmented into skin infections, respiratory infections, urinary tract infections (UTI), septicemia, ear infections, gastrointestinal infections, and others. The respiratory infections held the largest share of the market in 2023.
• Based on route of administration, the South & Central America antibiotics & antimycotics market is segmented into oral, topical, and others. The oral held the largest share of the market in 2023.
• Based on distribution channel, the South & Central America antibiotics & antimycotics market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies held the largest share of the market in 2023.

South & Central America Antibiotics & Antimycotics Market Outlook

The pharmaceutical industry emphasizes incorporating intelligent technologies such as deep learning, artificial intelligence (AI), and machine learning in the development of new antibiotics. Researchers are working to establish tools and platforms for identifying new active compounds. Harnessing the capabilities of novel technologies in new antibiotic discoveries is expected to change the overall course of antibiotic and antimycotic development and approval processes. 

Developing antibiotics for Gram-negative bacteria poses a significant challenge to researchers, and many drugs are still in the development phases. Limited permeability across the envelope of these bacteria due to nutrient-specific protein channels (porins) restricts the movement of non-essential molecules (including antibiotics) across membranes. Considering the difficulties around cell membrane permeability, researchers have developed a new Computational Antibiotic Screening Platform (CLASP) that helps identify potential drug molecules based on the analysis of porins. Advantages such as coarse grain (CG) resolution, advanced sampling techniques, and a parallel computing environment maximize the performance of CLASPs. The platform provides complete thermodynamic and kinetic results for a potential drug molecule under study in a few hours. It also helps understand or identify small molecule libraries that yield structure–property relationships to discover antibiotics with high permeability.

There is a rising inclination toward precision medicine approaches that involve adjusting antibiotic treatments based on patients’ genetic profiles and resistance patterns that are common among large populations. Such a revolution would improve drugs’ functionality while ensuring minimal adverse effects and curbing the development of resistance. Phage therapy has emerged as another novel approach that involves a potential combination of traditional microbial treatments with bacteriophages to target and destroy antibiotic-resistant pathogens. Promising recent advancements in gene-editing technologies, such as CRISPR, has the ability to further enhance the prospects of phage therapy. Thus, technological advancements in drug development and treatment delivery approaches are expected to bring new growth trends in the antibiotics and antimycotics market growth in the coming years.

South & Central America Antibiotics & Antimycotics Market Country Insights

Based on country, the South & Central America antibiotics & antimycotics market comprises Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2023.

In Brazil, the antibiotics and antimycotics market is growing due to the increasing prevalence of bacterial and fungal infections and a growing awareness of antimicrobial resistance. The increasing prevalence of hospital-acquired infections and a greater incidence of diseases such as pneumonia and tuberculosis, along with the surging prevalence of fungal infections among immuno-compromised patients, are creating demand for antibiotics. According to the Kolplast Group 2024 report, the hospital infection rates range from 5% to 14% of all hospitalizations in Brazil, representing a significant challenge for public health, which impacts the quality of care. Brazil faces significant public health challenges, making effective treatment options essential. Azithromycin, cefalexin, and amoxicillin are the most commonly prescribed antibiotics in Brazil for the treatment of various bacterial infections. ANVISA (National Health Surveillance Agency) and other regulatory bodies oversee the market, ensuring the safety and efficacy of antibiotics and antimycotics medications while promoting responsible use through public health initiatives. Moreover, increasing strategic initiatives by market players such as product launches, approval, and partnerships are expected to contribute to the market growth during the forecast period. For instance, in March 2024, Biocomposites received approval for STIMULAN as a calcium matrix antibiotic carrier for use across Brazil in wound healing as well as the treatment of bacterial infection.

South & Central America Antibiotics & Antimycotics Market Report Highlights

Report Attribute	Details
Market size in 2023	US$ 2,968.59 Million
Market Size by 2031	US$ 4,220.27 Million
CAGR (2023 - 2031)	4.5%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Drug Class Penicillin Cephalosporines Carbapenems Macrolides Aminoglycosides Quinolones Sulfonamides Tetracyclines Azoles Others By Indication Skin Infections Respiratory Infections Urinary Tract Infections Septicemia Ear Infections Gastrointestinal Infections Others By Route Of Administration Oral Topical Others By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
Regions and Countries Covered	South and Central America Brazil Argentina Rest of South and Central America
Market leaders and key company profiles	Pfizer Inc Novartis AG Sanofi SA F. Hoffmann-La Roche Ltd Merck & Co Inc GSK Plc Johnson & Johnson Cipla Ltd Bayer AG AbbVie Inc

Get more information on this report Request Free Sample PDF

South & Central America Antibiotics & Antimycotics Market Company Profiles

Some of the key players operating in the market are Pfizer Inc, Novartis AG, Sanofi SA, F. Hoffmann-La Roche Ltd, Merck & Co Inc, GSK Plc, Johnson & Johnson, Cipla Ltd, Bayer AG, AbbVie Inc, and Astellas Pharma Inc, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South & Central America Antibiotics & Antimycotics Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

South & Central America Antibiotics & Antimycotics Market Country and Regional Insights